BlackRock Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $282M | Buy |
|
|||||
|
2016
Q3 | $275M | Buy |
|
|||||
|
2016
Q2 | $94.6M | Buy |
|
|||||
|
2016
Q1 | $93.3M | Sell |
|
|||||
|
2015
Q4 | $135M | Sell |
|
|||||
|
2015
Q3 | $112M | Buy |
|
|||||
|
2015
Q2 | $125M | Buy |
|
|||||
|
2015
Q1 | $81.5M | Buy |
|
|||||
|
2014
Q4 | $85.9M | Sell |
|
|||||
|
2014
Q3 | $77.1M | Sell |
|
|||||
|
2014
Q2 | $73.1M | Buy |
|
|||||
|
2014
Q1 | $57.1M | Buy |
|
|||||
|
2013
Q4 | $45.4M | Sell |
|
|||||
|
2013
Q3 | $41.2M | Sell |
|
|||||
|
2013
Q2 | $45M | Buy |
|